VOICED : Laboratorio chino Sinovac duplica capacidad de producción de vacunas anticovid-19

Sinovac, a Chinese laboratory, has doubled its vaccine production capacity by completing a third production line, allowing it to produce 2 billion doses annually. The CoronaVac vaccine, approved by Beijing, requires two doses per patient. Studies in Brazil show it is 50% effective in preventing infection and 80% effective in avoiding medical intervention. Sinovac has distributed 200 million doses to over 20 countries and received approval to market in more than 30 nations. The WHO has deemed Sinovac and Sinopharm vaccines safe and effective but requires more data on elderly and those with pre-existing conditions before broader recommendations.

How many doses can Sinovac produce annually after expanding its production capacity?

• 3 billion doses

• 1 billion doses

• 2 billion doses

• 500 million doses

What is the name of the vaccine produced by Sinovac?

• Sinopharm

• CoronaVac

• Pfizer

• Moderna

According to studies in Brazil, what is the efficacy of CoronaVac in preventing medical intervention?

• 70%

• 50%

• 80%

• 60%

How many countries have received doses of the Sinovac vaccine?

• 20 countries

• 25 countries

• 15 countries

• 10 countries

What additional data does the WHO require before recommending Sinovac's vaccine for certain groups?

• Data on healthcare workers

• Data on elderly and those with other conditions

• Data on children

• Data on pregnant women